{"entity":{"type":"insider","cik":"0001856081","url":"/insider/0001856081","json_url":"/insider/0001856081.json","name":"Virani Shafique","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":17,"first":"2022-08-17","last":"2024-01-18","span_basis":"filed_date"},"name_variants":[{"name":"Virani Shafique","source":"filing","n_filings":17,"first_seen":"2022-08-17","last_seen":"2024-01-18"}],"transactions":[{"id":3247239,"accession":"0001209191-24-001870","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001870","line_url":"/filing/0001209191-24-001870#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":10.93,"price_display":"10.93","price_state":"stated","total_value":196740.0,"total_display":"196,740.00","total_whole":"196,740","shares_owned_after":136748.0,"shares_owned_after_display":"136,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-18","scope":"insider"},{"id":8727618,"accession":"0001209191-23-059254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-059254","line_url":"/filing/0001209191-23-059254#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":9.6,"price_display":"9.60","price_state":"stated","total_value":172800.0,"total_display":"172,800.00","total_whole":"172,800","shares_owned_after":136748.0,"shares_owned_after_display":"136,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-19","scope":"insider"},{"id":7973922,"accession":"0001209191-23-055843","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-055843","line_url":"/filing/0001209191-23-055843#line-3","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":6.51,"price_display":"6.51","price_state":"stated","total_value":117180.0,"total_display":"117,180.00","total_whole":"117,180","shares_owned_after":140351.0,"shares_owned_after_display":"140,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":7871919,"accession":"0001209191-23-053107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-053107","line_url":"/filing/0001209191-23-053107#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":6.3,"price_display":"6.30","price_state":"stated","total_value":113400.0,"total_display":"113,400.00","total_whole":"113,400","shares_owned_after":140351.0,"shares_owned_after_display":"140,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider"},{"id":8630462,"accession":"0001209191-23-050033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050033","line_url":"/filing/0001209191-23-050033#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":8.66,"price_display":"8.66","price_state":"stated","total_value":155880.0,"total_display":"155,880.00","total_whole":"155,880","shares_owned_after":140351.0,"shares_owned_after_display":"140,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-19","scope":"insider"},{"id":8501372,"accession":"0001209191-23-046424","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-046424","line_url":"/filing/0001209191-23-046424#line-3","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":9.25,"price_display":"9.25","price_state":"stated","total_value":166500.0,"total_display":"166,500.00","total_whole":"166,500","shares_owned_after":140351.0,"shares_owned_after_display":"140,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-17","scope":"insider"},{"id":8116162,"accession":"0001209191-23-043581","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-043581","line_url":"/filing/0001209191-23-043581#line-4","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.41,"price_display":"14.41","price_state":"stated","total_value":288200.0,"total_display":"288,200.00","total_whole":"288,200","shares_owned_after":143954.0,"shares_owned_after_display":"143,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-26","filed_date":"2023-07-27","scope":"insider"},{"id":8116157,"accession":"0001209191-23-043581","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-043581","line_url":"/filing/0001209191-23-043581#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.3,"price_display":"14.30","price_state":"stated","total_value":286000.0,"total_display":"286,000.00","total_whole":"286,000","shares_owned_after":143954.0,"shares_owned_after_display":"143,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-27","scope":"insider"},{"id":8657467,"accession":"0001209191-23-042794","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-042794","line_url":"/filing/0001209191-23-042794#line-4","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":13.74,"price_display":"13.74","price_state":"stated","total_value":412200.0,"total_display":"412,200.00","total_whole":"412,200","shares_owned_after":143954.0,"shares_owned_after_display":"143,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-18","filed_date":"2023-07-19","scope":"insider"},{"id":8657461,"accession":"0001209191-23-042794","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-042794","line_url":"/filing/0001209191-23-042794#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":11.72,"price_display":"11.72","price_state":"stated","total_value":351600.0,"total_display":"351,600.00","total_whole":"351,600","shares_owned_after":143954.0,"shares_owned_after_display":"143,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-19","scope":"insider"},{"id":8022837,"accession":"0001209191-23-038616","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-038616","line_url":"/filing/0001209191-23-038616#line-4","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":282300.0,"total_display":"282,300.00","total_whole":"282,300","shares_owned_after":143954.0,"shares_owned_after_display":"143,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-20","scope":"insider"},{"id":8022833,"accession":"0001209191-23-038616","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-038616","line_url":"/filing/0001209191-23-038616#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":9.67,"price_display":"9.67","price_state":"stated","total_value":290100.0,"total_display":"290,100.00","total_whole":"290,100","shares_owned_after":143954.0,"shares_owned_after_display":"143,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":7835507,"accession":"0001209191-23-034601","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-034601","line_url":"/filing/0001209191-23-034601#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17865.0,"shares_display":"17,865","price_per_share":8.93,"price_display":"8.93","price_state":"stated","total_value":159534.45,"total_display":"159,534.45","total_whole":"159,534","shares_owned_after":143954.0,"shares_owned_after_display":"143,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-02","filed_date":"2023-06-05","scope":"insider"},{"id":7835504,"accession":"0001209191-23-034601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-034601","line_url":"/filing/0001209191-23-034601#line-1","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":8.58,"price_display":"8.58","price_state":"stated","total_value":214500.0,"total_display":"214,500.00","total_whole":"214,500","shares_owned_after":161819.0,"shares_owned_after_display":"161,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-05","scope":"insider"},{"id":8325670,"accession":"0001209191-23-010774","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-010774","line_url":"/filing/0001209191-23-010774#line-4","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1768.0,"shares_display":"1,768","price_per_share":8.42,"price_display":"8.42","price_state":"stated","total_value":14886.56,"total_display":"14,886.56","total_whole":"14,887","shares_owned_after":187332.0,"shares_owned_after_display":"187,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":8325666,"accession":"0001209191-23-010774","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-010774","line_url":"/filing/0001209191-23-010774#line-3","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7486.0,"shares_display":"7,486","price_per_share":8.33,"price_display":"8.33","price_state":"stated","total_value":62358.38,"total_display":"62,358.38","total_whole":"62,358","shares_owned_after":189846.0,"shares_owned_after_display":"189,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-15","filed_date":"2023-02-17","scope":"insider"},{"id":8627058,"accession":"0001209191-23-004043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-004043","line_url":"/filing/0001209191-23-004043#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":9.1561,"price_display":"9.16","price_state":"stated","total_value":91561.0,"total_display":"91,561.00","total_whole":"91,561","shares_owned_after":73160.0,"shares_owned_after_display":"73,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6213787,"accession":"0001209191-22-061999","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-061999","line_url":"/filing/0001209191-22-061999#line-2","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":8.8525,"price_display":"8.85","price_state":"stated","total_value":88525.0,"total_display":"88,525.00","total_whole":"88,525","shares_owned_after":78160.0,"shares_owned_after_display":"78,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":6278668,"accession":"0001209191-22-057708","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-057708","line_url":"/filing/0001209191-22-057708","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.31227973,"price_display":"12.31","price_state":"stated","total_value":123122.7973,"total_display":"123,122.80","total_whole":"123,123","shares_owned_after":88101.0,"shares_owned_after_display":"88,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider","n_lines":2},{"id":6374613,"accession":"0001209191-22-053981","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-053981","line_url":"/filing/0001209191-22-053981","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":10.91795,"price_display":"10.92","price_state":"stated","total_value":109179.5,"total_display":"109,179.50","total_whole":"109,180","shares_owned_after":93773.0,"shares_owned_after_display":"93,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-14","filed_date":"2022-10-18","scope":"insider","n_lines":2},{"id":6126822,"accession":"0001209191-22-050400","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-050400","line_url":"/filing/0001209191-22-050400","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.363476,"price_display":"13.36","price_state":"stated","total_value":133634.76,"total_display":"133,634.76","total_whole":"133,635","shares_owned_after":94173.0,"shares_owned_after_display":"94,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-16","scope":"insider","n_lines":2},{"id":6517489,"accession":"0001209191-22-046464","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-046464","line_url":"/filing/0001209191-22-046464#line-3","is_derivative":false,"issuer_cik":"0001601830","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001601830","owner_cik":"0001856081","owner_name":"Virani Shafique","owner_display_name":"Virani Shafique","owner_url":"/insider/0001856081","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":12.6148,"price_display":"12.61","price_state":"stated","total_value":378444.0,"total_display":"378,444.00","total_whole":"378,444","shares_owned_after":98773.0,"shares_owned_after_display":"98,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001601830","name":"RECURSION PHARMACEUTICALS, INC.","url":"/issuer/0001601830","role":"Officer (Chief Business Officer)","n_filings":17,"first_seen":"2022-08-17","last_seen":"2024-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001856081","retrieved_at":"2026-08-25T10:32:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}